A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke
Clinical trial NCT04309474 · COMPLETED
Trial details
- NCT number
- NCT04309474
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2024-04-18
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.